Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MC Strong Drop
- Development stage
- Unknown
- Lead developer
- DEMECAN
- Administration
- Inhalation, Oral
01
Overview
MC Strong Drop is a medical cannabis flower product distributed by the German pharmaceutical company DEMECAN. Cultivated in Canada, it is an unirradiated (unbestrahlt) Indica-dominant hybrid strain (with cultivars including Magic Marker #2, Sky Pie, and Zkittlez x Sherb Bx1 x Permanent Marker). The product typically features a high tetrahydrocannabinol (THC) content of approximately 26% to 27% and a low cannabidiol (CBD) content of less than 1%. It is prescribed in Germany for the management of conditions such as chronic pain, depression, stress, anxiety, and sleep disorders, and is administered via inhalation or oral preparation.
- Brand names
- MC Strong Drop
- Other names
- Demecan 27/1 MC Strong DropDemecan 27:01 MC Strong DropDemecan MC Strong DropDemecan MC Strong Drop 27/1
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on MC Strong Drop.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MC Strong Drop.